Vimarsana
Biggest News Aggregation in the World

Page 7 - Compugen Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Compugen Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Compugen Ltd Today - Breaking & Trending Today

Why Is Cancer Immunotherapy-Focused Compugen Stock Is Trading Higher Today? - Compugen (NASDAQ:CGEN) - Vimarsana News

Why Is Cancer Immunotherapy-Focused Compugen Stock Is Trading Higher Today? - Compugen (NASDAQ:CGEN)

Gilead Sciences Inc (NASDAQ: GILD) announced an agreement with Compugen Ltd (NASDAQ: CGEN) to license its pre-clinical antibody program against IL-18 binding protein exclusively, including the 

Dow Jumps 150 Points; FactSet Shares Rise After Q1 Results - BYND Cannasoft Enterprise (NASDAQ:BCAN), Biodexa Pharmaceuticals (NASDAQ:BDRX) - Vimarsana News

Dow Jumps 150 Points; FactSet Shares Rise After Q1 Results - BYND Cannasoft Enterprise (NASDAQ:BCAN), Biodexa Pharmaceuticals (NASDAQ:BDRX)

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 150 points on Tuesday. The Dow traded up 0.46% to 37,476.21 while the NASDAQ rose 0.41% to 14,966.74. The S&P 500 also rose, gaining, 0.38% to 4,758.55.

Compugen signs cancer drug licensing deal with Gilead Sciences - Vimarsana News

Compugen signs cancer drug licensing deal with Gilead Sciences

Under the terms of the deal, Gilad will make an immediate payment of $60 million to Compugen with potential milestone payments of up to $890 million plus royalties.

Crude Oil Rises Over 1%; Biodexa Pharmaceuticals Shares Plunge - BYND Cannasoft Enterprise (NASDAQ:BCAN), Biodexa Pharmaceuticals (NASDAQ:BDRX) - Vimarsana News

Crude Oil Rises Over 1%; Biodexa Pharmaceuticals Shares Plunge - BYND Cannasoft Enterprise (NASDAQ:BCAN), Biodexa Pharmaceuticals (NASDAQ:BDRX)

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 200 points on Tuesday. The Dow traded up 0.53% to 37,505.25 while the NASDAQ rose 0.51% to 14,980.71. The S&P 500 also rose, gaining, 0.45% to 4,762.12.

Compugen's stock rockets on deal with Gilead for anti-tumor drug - Vimarsana News

Compugen's stock rockets on deal with Gilead for anti-tumor drug

The Entire Business World on a Single Page with the Web's Most Comprehensive One-Stop Finance News Hub.

Source: biztoc.com